Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Bortezomib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 396 Neoplasms, Plasma Cell 64 Lymphoma, Mantle-Cell 58 Recurrence 53 Lymphoma 52 Lymphoma, Non-Hodgkin 35 Leukemia, Myeloid, Acute 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Lymphoma, Follicular 33 Waldenstrom Macroglobulinemia 31 Lymphoma, Large B-Cell, Diffuse 28 Lymphoma, B-Cell, Marginal Zone 25 Immunoglobulin Light-chain Amyloidosis 23 Carcinoma, Non-Small-Cell Lung 23 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms 20 Leukemia 19 Hodgkin Disease 15 Hematologic Neoplasms 15 Breast Neoplasms 12 Lymphoma, Large-Cell, Anaplastic 11 Lymphoma, B-Cell 11 Burkitt Lymphoma 11 Myelodysplastic Syndromes 10 Mycosis Fungoides 10 Lymphoma, T-Cell, Peripheral 10 Immunoblastic Lymphadenopathy 10 Congenital Abnormalities 10 Unspecified Adult Solid Tumor, Protocol Specific 9 Sezary Syndrome 9

Interventions

efgartigimod alfa 10 rozanolixizumab 9 Prednisone 8 zilucoplan 7 Pyridostigmine Bromide 7 Cyclophosphamide 7 telitacicept 6 Tacrolimus 6 Rituximab 6 ravulizumab 5 fludarabine 5 eculizumab 5 Mycophenolic Acid 4 Hizentra 4 Steroids 3 Immunoglobulins, Intravenous 3 HBM9161 3 Data Collection 3 Azathioprine 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Blood Specimen Collection 2 tofacitinib 1 tocilizumab 1 satralizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02102594 2019-12-03

TAVAB

Charite University, Berlin, Germany

Phase 2 Terminated

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡